Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Strome

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|July 31, 2009
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patientsKathleen Settle, Marshall R Posner, Lisa M Schumaker, et al.
Blood|June 4, 2008
Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodiesWei Lin, Caroline J Voskens, Xiaoyu Zhang, et al.
Head & Neck|December 10, 2014
Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer CenterDan P Zandberg, Sandy Liu, Olga Goloubeva, et al.
The Laryngoscope|March 5, 2003
Swallow function in patients before and after intra-arterial chemoradiationDarlene E Graner, Robert L Foote, Jan L Kasperbauer, et al.
Head & Neck|March 15, 2019
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavityDan P Zandberg, Luke J Tallon, Sushma Nagaraj, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
CD137 promotes proliferation and survival of human B cellsXiaoyu Zhang, Caroline J Voskens, Michelle Sallin, et al.
JCI Insight|January 25, 2019
A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunityXiaoyu Zhang, Jane Owens, Henrik S Olsen, et al.
Head & Neck|January 31, 2012
Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinomaCaroline J Voskens, Duane Sewell, Ronna Hertzano, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetR Houston Thompson, Michael D Gillett, John C Cheville, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancerAjay Jain, Bhawna Poonia, Edward C So, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Cancer Prevention Research (Philadelphia, Pa.)|July 31, 2009
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patientsKathleen Settle, Marshall R Posner, Lisa M Schumaker, et al.
Blood|June 4, 2008
Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodiesWei Lin, Caroline J Voskens, Xiaoyu Zhang, et al.
Head & Neck|December 10, 2014
Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer CenterDan P Zandberg, Sandy Liu, Olga Goloubeva, et al.
The Laryngoscope|March 5, 2003
Swallow function in patients before and after intra-arterial chemoradiationDarlene E Graner, Robert L Foote, Jan L Kasperbauer, et al.
Head & Neck|March 15, 2019
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavityDan P Zandberg, Luke J Tallon, Sushma Nagaraj, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
CD137 promotes proliferation and survival of human B cellsXiaoyu Zhang, Caroline J Voskens, Michelle Sallin, et al.
JCI Insight|January 25, 2019
A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunityXiaoyu Zhang, Jane Owens, Henrik S Olsen, et al.
Head & Neck|January 31, 2012
Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinomaCaroline J Voskens, Duane Sewell, Ronna Hertzano, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetR Houston Thompson, Michael D Gillett, John C Cheville, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancerAjay Jain, Bhawna Poonia, Edward C So, et al.
Pageof 9